Stay updated on Encorafenib Combo With Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Encorafenib Combo With Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Encorafenib Combo With Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The record presents details of a completed melanoma trial investigating encorafenib, binimetinib, and pembrolizumab, including its study design, participant criteria, locations, and measured outcomes.
    Difference
    60%
    Check dated 2026-11-09T13:25:20.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer now identifies the site revision as v3.8.0 instead of v3.7.2. The study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T13:21:57.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A notice announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-26T15:13:02.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T14:58:08.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The 403 error page’s footer revision identifier changes from v3.7.0 to v3.7.1; the page content and layout otherwise remain unchanged.
    Difference
    0.2%
    Check dated 2026-10-12T15:24:57.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record details, blocking access to the IMMU-TARGET study information on ClinicalTrials.gov.
    Difference
    20%
    Check dated 2026-09-21T22:21:56.000Z thumbnail image

Stay in the know with updates to Encorafenib Combo With Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Encorafenib Combo With Pembrolizumab in Melanoma Clinical Trial page.